Carregant...

Clinical development of fenretinide as an antineoplastic drug: Pharmacology perspectives

Fenretinide (4-HPR) is a synthetic retinoid that has cytotoxic activity against cancer cells. Despite substantial in vitro cytotoxicity, response rates in early clinical trials with 4-HPR have been less than anticipated, likely due to the low bioavailability of the initial oral capsule formulation....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Exp Biol Med (Maywood)
Autors principals: Cooper, Jason P, Reynolds, C Patrick, Cho, Hwangeui, Kang, Min H
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2017
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5478002/
https://ncbi.nlm.nih.gov/pubmed/28429653
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370217706952
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!